News

Guest User 6/3/22 Guest User 6/3/22

Pfizer Doses

Pfizer Doses First Patients as Part of Global Achondroplasia Phase 2 Development Program

Read More

Guest User 6/3/22 Guest User 6/3/22

VectivBio Strengthens

VectivBio Strengthens Business Development Capabilities with Key Appointments

Read More

Guest User 6/3/22 Guest User 6/3/22

Find Therapeutics

Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal

Read More